Skip to content

Author

A. Mirelman

We have 3 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Meaningful digital mobility outcomes for people with Parkinson's disease: Insights grounded in diverse lived experience

Background Digital mobility outcomes (DMOs) have been cited as potential clinical endpoints for trials in Parkinson's disease (PD). Current evidence from the Mobilise-D consortium suggests that selected DMOs are technically valid, with emerging research on their clinical validity. However, regulatory qualification of D...

Jack Lumsdon, Ríona Mc Ardle, Megan Hanrahan et al. · 0 citations
Open access Sep 2026

The Effect of LRRK2 and GBA1 Mutations on Survival in Early- and Late-Onset Parkinson's Disease.

BACKGROUND Mutations in the glucocerebrosidase 1 (GBA1) and leucine-rich repeat kinase 2 (LRRK2) genes are associated with Parkinson's disease (PD) phenotype. OBJECTIVE To asses the contribution of genetic status to long-term survival of patients with PD. METHODS A total of 2039 PD patients with Ashkenazi ancestry...

Raz Rubin, R. Alcalay, Nurit Omer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.